The COVID-19 vaccination campaign in Switzerland and its impact on disease spread

被引:0
|
作者
Dunbar, M. Bekker-Nielsen [1 ,2 ]
Held, L. [1 ]
机构
[1] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland
[2] Oslo Metropolitan Univ, Ctr Res Pandem & Soc, OsloMet, Oslo, Norway
关键词
Vaccination coverage; Infectious disease surveillance; Endemic-epidemic modelling; Coronavirus disease 2019 (COVID-19);
D O I
10.1016/j.epidem.2024.100745
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We analyse infectious disease case surveillance data to estimate COVID-19 spread and gain an understanding of the impact of introducing vaccines to counter the disease in Switzerland. The data used in this work is extensive and detailed and includes information on weekly number of cases and vaccination rates by age and region. Our approach takes into account waning immunity. The statistical analysis allows us to determine the effects of choosing alternative vaccination strategies. Our results indicate greater uptake of vaccine would have led to fewer cases with a particularly large effect on undervaccinated regions. An alternative distribution scheme not targeting specific age groups also leads to fewer cases overall but could lead to more cases among the elderly (a potentially vulnerable population) during the early stage of prophylaxis rollout.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Go To Travel campaign and the geographic spread of COVID-19 in Japan
    Asami Anzai
    Sung-mok Jung
    Hiroshi Nishiura
    BMC Infectious Diseases, 22
  • [32] The impact of COVID-19 on mobility choices in Switzerland
    Hintermann, Beat
    Schoeman, Beaumont
    Molloy, Joseph
    Schatzmann, Thomas
    Tchervenkov, Christopher
    Axhausen, Kay W.
    TRANSPORTATION RESEARCH PART A-POLICY AND PRACTICE, 2023, 169
  • [33] COVID-19 Spread Prediction and Its Impact on the Stock market price
    Khan, Musa
    Khan, Gul Muhammad
    PROCEEDINGS OF 2ND IEEE INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (ICAI 2022), 2022, : 140 - 146
  • [34] Between information campaign and controversy: a quantitative newspaper content analysis about COVID-19 vaccination in Switzerland and Austria
    Zimmermann, Bettina M.
    Paul, Katharina T.
    Janny, Anna
    Butt, Zarah
    SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2024, 52 (03) : 253 - 261
  • [35] COVID-19 vaccination and liver disease
    Sotaro Ozaka
    Takashi Kobayashi
    Kazuhiro Mizukami
    Kazunari Murakami
    World Journal of Gastroenterology, 2022, 28 (48) : 6791 - 6810
  • [36] COVID-19 and epilepsy: Disease or vaccination?
    Odintsova, Galina
    Bannikova, Valentina
    Koloteva, Anna
    Nezdorovin, Oleg
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 146 - 146
  • [37] COVID-19 vaccination and liver disease
    Ozaka, Sotaro
    Kobayashi, Takashi
    Mizukami, Kazuhiro
    Murakami, Kazunari
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (48) : 6791 - 6810
  • [38] Kikuchi disease and COVID-19 vaccination
    Yu, Shan-Chi
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 161 (02) : 206 - 207
  • [39] Graves' disease, COVID-19, and vaccination
    Famularo, Giuseppe
    Baldelli, Roberto
    MINERVA ENDOCRINOLOGY, 2022, 47 (04): : 476 - 477
  • [40] How education and GDP drive the COVID-19 vaccination campaign
    Ngo, Vu M.
    Zimmermann, Klaus F.
    Nguyen, Phuc, V
    Huynh, Toan L. D.
    Nguyen, Huan H.
    ARCHIVES OF PUBLIC HEALTH, 2022, 80 (01)